The in vitro activity and the in vivo properties of cefuroxime, previously described by Eykyn et al. (1976) and Ryan et al. (1976) show this new semi-synthetic cephalosporin to have marked stability to most of the fl-lactamases produced by Gram negative bacteria ) and some favourable pharmacokinetic properties (Foord 1976 ).
Factors that determine success or failure in treating bronchopulmonary bacterial infections include two main criteria: the sensitivity of the microorganisms to available antibiotics and the penetration of the drugs at the site of infection in suitable concentrations (Bergogne-Berezin et al. 1976 , Pennington 1976 .
The characteristics of cefuroxime assure its antibacterial activity against the resistant bacteria of bronchopulmopary tract infections but the pharmacological criterion of penetration of the drug at the site of infection remained to be determined.
The aim of this pharmacokinetic study was to assess cefuroxime concentrations achieved in bronchial secretions in patients with bronchopulmonary infections. The bronchial secretions were collected through a tracheostomy cannula or by fibroscopy. Antibiotic determinations in serum and endobronchial samples were made simultaneously in order to establish the relationship between the serum and the bronchial levels.
MATERIALS AND METHODS

Patients
Specimens of bronchial secretions and serum samples were taken from 14 patients with tracheostomrry. They were chiefly male, as usual in bronchopulmonary disease, and their ages ranged from 40-79. All had been admitted to hospital for severe lung disease with an acute exacerbation of respiratory tract infection and with purulent or mucopurulent expectoration. They received 48 h treatment with cefuroxime administered i.m., 750 mg every 8 h. In some patients, bronchial secretions were collected by fibroscopy after one single dose of cefuroxime.
Samples
Paired specimens of serum and bronchial secretions were collected through the tracheostomy cannula which allowed easy access to the tracheo-bronchial tree and allowed multiple samples to be collected at different times. In some patients the samples were collected by fibroscopy. All the samples were immediately frozen at -200C before assay.
Assay Methods
All serum and bronchial secretion assays were carried out by the microbiological agar diffusion method of Grove & Randall (1955) . The medium was Oxoid Antibiotic Medium No. 2 with 3 g/ litre of sodium citrate added. The test organisms were Bacillus subtilis (1904 E) for cefuroxime assays in the range 10-0.62 ptg/ml, and Bacillus subtilis (MB 32 SDR) for sensitive cefuroxime assays in the range 2.0-0.1 ,tg/ml. Both were used in spore suspensions diluted and added to the molten agar in order to achieve a final concentration of 1 %. Antibiotic standards were included with each assay plate. All tests and standards were done in quadruplicate and allotted to random positions on the assay plate. After overnight incubation at 37°C, the zone diameters were measured and the levels of antibiotic activity plotted by interpolation from the standard curve for that assay plate. Table I summarizes the serum concentration findings and shows individual serum concentrations of cefuroxime at various times after the 750 mg dose. Only 4 patients were studied completely. The mean serum concentrations in this study should be compared to the previous results of Foord (1976) that show a comparable pattern, after the same i.m. dosage. Thus the peak level in this study occurred at 30 min. In Foord's study it was given as 29-45 min. The peak level is high, reaching an average of 22 jug/ml. The concentration slope shows significant concentrations even at later periods. At 5.5 h for example, the mean serum concentration is still 4.8 jug/ml. tions ratio was about 13 % at the second hour after dosing.
Results
Discussion
The measurement of antibiotic concentrations in infected human bronchial secretions is of importance in planning an efficacious regimen of antibiotic therapy in respiratory tract infections.
Although concentrations in bronchial secretions may not be equivalent to local tissue levels at the site of infection, the correlations between bronchial secretions levels and bronchopulmonary tissue levels seems to be good. Various host and drug factors may influence the rate of drug penetration through the blood-bronchus barrier.
Host factors like the choice of patients with bronchopulmonary infections may interfere with the results of the study since the rate of penetration of antibiotics is favoured by the inflammation of the bronchi.
It is well known that inflammation increases the passage of antibiotics through bloodbronchoalveolar barrier (Pennington 1976 , Wong & Perce 1973 . Studies with ampicillin (May 1964 , Stewart et al. 1970 and cephalexin (Halprin & McMahon 1973) have shown that the penetration of these drugs into sputum was increased by purulence. In the same way Ingold (1975) studied the correlation between the purulence of the sputum and the levels of amoxycillin. In this study of cefuroxime, a correlation between the rate of penetration and bronchial inflammation is evident since the degree of macroscopic purulence of bronchial secretions was very high in all samples. The sampling conditions were the best possible since the bronchial secretions were taken in situ through the tracheostomy cannula. This process eliminates saliva, which is an important dilution factor. Change in Bronchial Concentration of Cefuroxime with Time In this study specimens were collected at various precisely measured intervals following antibiotic administration. This refinement, which may permit study of various drug kinetics in man, was especially established for cefuroxime. The results show an early concentration in bronchial secretions (Tables 1 and 2) while serum concentrations decrease rapidly. These results differ markedly from previous studies (Halprin & McMahon 1973 , Pennington & Reynolds 1973 , Wong & Perce 1973 with other agents that exhibited a delayed increase of antibiotic concentration in bronchial secretions.
In addition, the concentration of cefuroxime achieved in bronchial secretions are in a steady state for a long period, since they are about 1.5 ,ug/ml in the early samples (10-30 min), and min in this study, and accords with the value previously reported by Foord (1976) .
Bronchial concentrations (Table 2) : Individual and mean values reached more than 1 ,tg/ml in 15 min rising to 1.56 ,ug/ml at 30 min. The bronchial peak, 60 min after cefuroxime administration, was 2.35 ,ug/ml. The bronchial levels remained relatively high even at 5.5 h.
Bronchial/serum ratios (Table 3) : The ratio rose progressively from 7% to 18% at 2 h, and fell slowly later, remaining at 12% at the time of the last sampling. During the second hour the bronchial concentration of cefuroxime were about 20% of the corresponding serum level, as is usual for cephalosporins (Bergogne-Berezin et al. 1976 ).
In bronchial secretions taken fibroscopy in patients receiving a single dose of cefuroxime (Table 4) , the concentrations were slightly lower than in bronchial secretions taken after 48 h of treatment. The mean bronchial concentration was 1.38 jug/ml and the bronchial/serum concentra-Cefuroxime are still 1.96 ,ug at 2 h and 0.58 jig even 5.3 h after the administration of the drug.
Correlation with Serum Levels
The mode of transport of drugs from the blood to the bronchial lumen may influence their rate of penetration. Almost all studies (Bodin et al. 1975 , May & Delves 1965 , Stewart et al. 1970 show that higher doses of antibiotics produce higher serum and bronshial concentrations. The same correlations were found in previous studies with amoxycillin by Ingold (1975) . This suggests that some antibiotics may be transported from blood to bronchus by simple diffusion. Thus, raising the dose of the administered drug would be expected to increase serum and bronchial levels.
However, a few studies (May & Delves 1965 , Saggers & Lawson 1968 ) have shown, particularly for ampicillin, that increasing the administered dose increased the serum concentration, but the bronchial concentrations correlated only poorly with the serum levels. These results imply an independent relationship between serum and bronchial concentrations for ampicillin, probably due to saturation of an active transport system governing ampicillin passage from blood to bronchus.
In the case of cefuroxime, serum levels were found to be very high in previous studies (Goodwin et al. 1977) and in the present experiments, although bronchial concentrations seemed to be lower than expected in comparison with serum levels. These results suggest an active transport mechanism for antibiotic movement across the blood-bronchus barrier. Unfortunately the present experiment did not use different dosages of the drug to demonstrate a possible saturation of penetration mechanism.
The concentrations of cefuroxime measured in bronchial secretions will be efficacious in the treatment of bronchopulmonary infections if they exceed the minimal inhibitory concentration (MIC) of the infecting organisms. In this study, the concentrations of cefuroxime measured in bronchial secretions were probably adequate to inhibit the most common pathogenic bacteria, especially Gram positive bacteria like S. pneumonia, and other Streptococci and/or susceptible Hawmophilus influenza,. In previous in vitro experiments (Foord 1976 , Grove & Randall 1955 , Ryan et al. 1976 ) it has been shown that the MICs for these species are very low, in general between Q.006 and 0.5 5ig/ml. The MICs of penicillin sensitive Staphylococci were 0.5 to 1 ,Lg/ml. For methicillin sensitive Staphylococci the MICs for cefuroxime were 0.25 ,g/ml, but methicillin resistant organisms exhibit MICs of about 6 ,tg/ml and could not be destroyed by the bronchial levels of cefuroxime.
Even though cefuroxime was shown in vitro to be the most active ofthe cephalosporins ), a probable lack ofefficacy at bronchial concentrations of the drug should be expected because of the high MIC values against the Gram negative bacilli. It is therefore of great interest to compare MIC and MBS values and to compare the concentrations of drugs in the bronchial secretions achieved with various given doses of antibiotics.
Concluisions
The measurement of the concentrations of antibiotics obtained in the bronchial secretions provides information on their diffusion characteristics and is a pharmacological criterion of possible efficacy of the drugs in the treatment of bronchopulmonary bacterial infections. In the case of cefuroxime administered i.m. the results of this study demonstrate a rapid passage of the drug through the blood-bronchus barrier. The serum concentrations are very high after 48 h treatment and decrease progressively.
The majority of the bronchial levels measured in this study are superior or at least equal to the MIC of sensitive organisms, even the samples taken at 4-5.5 h after administration. They decrease very slowly, and the ratio of bronchial and corresponding serum concentrations increases with time. The rate of penetration into the bronchial lumen is variable for different antibiotics. In the case of cefuroxime it is very different to the penicillins previously studied. In particular, cefuroxime attains effective concentrations earlier than other f-lactam antibiotics.
Since the passage of the drugs into the respiratory tract and bronchial lumen is unpredictable, this kind of experiment is of considerable importance, providing as it does information on the rate of the penetration of a given antibiotic through the blood-bronchus barrier.
Summary
Cefuroxime is a new cephalosporin antibiotic described as resistant to most of the ,-lactamases produced by Gram negative bacteria. The aim of this work was to assess cefuroxime concentrations in bronchial secretions following i.m. injections. The study was performed on patients with tracheostomy who received 48 h treatment, with injections of 750 mg of the drug every 8 h. After the last injection, bronchial mucus samples were collected through the tracheostomy cannula at 30 min, I h, 2 h, 4 h and 6 h. Blood samples were simultaneously collected to compare serum and bronchial levels of cefuroxime in the same patients. All samples were immediately frozen at -20°C before assay. Assays were performed according to the microbiological method of Grove & Randall (1955) with Bacillus subtilis (1904 E and MB 32) like test organisms.
The results of this study show that 1-4 h after injection, cefuroxime is present in significant quantities in bronchial mucus, reaching concentrations greater than, or at least equal to the MIC for sensitive organisms.
